MuMac ^Company

Mumac, a spin-out from The University of Manchester, was formed to manage the transfer of lab-based techniques into marketable products. MuMac Ltd. created optical technology RapiDA -a powerful new tool in the fight against Age-Related Macular Degeneration (AMD). AMD is the most significant cause of sight loss or blindness in the developed world. RapiDA’s early-alert digital screening process is a big step forward in tackling this major global health problem. RapiDA is Mumac’s first product and represents a significant step forward in diagnosing and monitoring AMD. Other innovative products are in the Mumac pipeline.